Omar Chehab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Omar Chehab has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
Mohit Pahuja
Department of Cardiology, MedStar Washington Hospital Center, Washington, DC, USA
13 shared publicationsAlexandros Briasoulis
Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
9 shared publicationsLuis Afonso
Division of Cardiology, Department of Internal Medicine, Wayne State University School of Medicine/Detroit Medical Center, Detroit, Michigan
8 shared publicationsAmjad Kanj
Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN, USA
7 shared publicationsSagar Ranka
Division of Cardiology, Department of Internal Medicine Kansas University Medical Center Kansas Kansas USA
7 shared publicationsTushar Mishra
Department of Internal Medicine Detroit Medical Center/Wayne State University School of Medicine Detroit Michigan USA
7 shared publications
Latest Publications
- 9 March 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Albuminuria linked with interstitial myocardial fibrosis at the population level: the multi-ethnic study of atherosclerosis
Introduction: Albuminuria is a significant marker for cardiovascular disease (CVD) in both diabetics and non-diabetics. However, its relationship with myocardial fibrosis in the general population remains unclear. Methods and results: The study included 2112 participants (52% female, mean age 69 ± 9 years) from the Multi-Ethnic Study of Atherosclerosis cohort who had urine albumin and creatinine measurements and underwent cardiac magnetic resonance with T1 mapping for myocardial fibrosis evaluation in 2010. Analyses were stratified by sex and diabetes stage. Multivariable linear and logistic regression models assessed associations of albuminuria/albumin–creatinine ratio (ACR) with extracellular volume (ECV), native T1 time, and myocardial scar. In fully adjusted models, a one-SD increase in log-transformed albumin and ACR was associated with 0.15% and 0.2% higher ECV and 2.7% and 2.6% higher native T1 time, respectively. In men, a one-SD increase in log-transformed albumin and ACR was associated with greater ECV (0.3% each) and higher native T1 time (3.3% and 2.6%, respectively). Among women, no significant associations with albuminuria or ACR were found. In participants with prediabetes, log-transformed urine albumin and ACR were positively associated with ECV (P < 0.05) but not with native T1. In diabetics, ACR showed a modest association with ECV and native T1, while log-transformed albumin was significantly associated with 0.3% greater ECV and 3% higher native T1 (P < 0.05). The odds of myocardial scar were not associated with higher albumin/ACR after adjusting for cardiovascular risk factors. Conclusion: Elevated albuminuria levels are related to subclinical fibrosis in a community-based setting, independent of traditional cardiovascular risk factors. This association was more prominent among prediabetics, diabetics, and among males.
- 9 March 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Albuminuria linked with interstitial myocardial fibrosis at the population level: the multi-ethnic study of atherosclerosis
Introduction: Albuminuria is a significant marker for cardiovascular disease (CVD) in both diabetics and non-diabetics. However, its relationship with myocardial fibrosis in the general population remains unclear. Methods and results: The study included 2112 participants (52% female, mean age 69 ± 9 years) from the Multi-Ethnic Study of Atherosclerosis cohort who had urine albumin and creatinine measurements and underwent cardiac magnetic resonance with T1 mapping for myocardial fibrosis evaluation in 2010. Analyses were stratified by sex and diabetes stage. Multivariable linear and logistic regression models assessed associations of albuminuria/albumin–creatinine ratio (ACR) with extracellular volume (ECV), native T1 time, and myocardial scar. In fully adjusted models, a one-SD increase in log-transformed albumin and ACR was associated with 0.15% and 0.2% higher ECV and 2.7% and 2.6% higher native T1 time, respectively. In men, a one-SD increase in log-transformed albumin and ACR was associated with greater ECV (0.3% each) and higher native T1 time (3.3% and 2.6%, respectively). Among women, no significant associations with albuminuria or ACR were found. In participants with prediabetes, log-transformed urine albumin and ACR were positively associated with ECV (P < 0.05) but not with native T1. In diabetics, ACR showed a modest association with ECV and native T1, while log-transformed albumin was significantly associated with 0.3% greater ECV and 3% higher native T1 (P < 0.05). The odds of myocardial scar were not associated with higher albumin/ACR after adjusting for cardiovascular risk factors. Conclusion: Elevated albuminuria levels are related to subclinical fibrosis in a community-based setting, independent of traditional cardiovascular risk factors. This association was more prominent among prediabetics, diabetics, and among males.
- Open Access
- 3 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (5) , e044664
Sex‐Difference of Associations Between Cigarette Smoking and Myocardial Fibrosis: The Multi‐Ethnic Study of Atherosclerosis
Background: Extracellular volume (ECV) and native T1 time (nT1) are markers of interstitial‐myocardial‐fibrosis by cardiac magnetic resonance and are associated with cardiovascular events, heart failure, and death. However, the association between smoking and interstitial‐myocardial‐fibrosis at the population level has not been explored. This cross‐sectional analysis of the MESA (Multi‐Ethnic Study of Atherosclerosis) cohort investigated the relationship between smoking and interstitial‐myocardial‐fibrosis by cardiac magnetic resonance, as well as the sex differences of this association. Methods: A total of 2118 participants (53% women) had data on smoking between 2000 and 2012 and ECV (%) and nT1 (ms) at exam 5 (2010–2012). We constructed participant‐specific trajectories of average cigarettes per day (ACPD) based on linear interpolation to estimate ACPD between exams 1 through 5 (ACPD 1‐5 ). We explored the associations of smoking status at exam 5, ACPD at exam 5, ACPD 1‐5 , and temporal change in smoking status, with ECV and nT1 using multivariable analysis. Results: Current smoking status was associated with increased markers of interstitial‐myocardial‐fibrosis in women but not in men, ECV% (ꞵ=2% P ≤0.001 versus 0.5%; P =0.2) and nT1 (ꞵ=28 ms; P ≤0.001 versus 3 ms; P =0.5) in women versus men, respectively. A higher ACPD 1‐5 was associated with increased ECV% (ꞵ=0.1%; P P =0.003) in women but not in men. Similarly, higher ACPD at exam 5 was associated with higher ECV% in women versus men. Sex interaction ascertained before stratification was statistically significant. Conclusions: In this population study, cigarette smoking was associated with a higher prevalence of interstitial‐myocardial‐fibrosis in women but not in men, indicating differences in the pathophysiology of cardiovascular disease by sex.
- 3 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (5) , e044664
Open AccessSex‐Difference of Associations Between Cigarette Smoking and Myocardial Fibrosis: The Multi‐Ethnic Study of Atherosclerosis
Background: Extracellular volume (ECV) and native T1 time (nT1) are markers of interstitial‐myocardial‐fibrosis by cardiac magnetic resonance and are associated with cardiovascular events, heart failure, and death. However, the association between smoking and interstitial‐myocardial‐fibrosis at the population level has not been explored. This cross‐sectional analysis of the MESA (Multi‐Ethnic Study of Atherosclerosis) cohort investigated the relationship between smoking and interstitial‐myocardial‐fibrosis by cardiac magnetic resonance, as well as the sex differences of this association. Methods: A total of 2118 participants (53% women) had data on smoking between 2000 and 2012 and ECV (%) and nT1 (ms) at exam 5 (2010–2012). We constructed participant‐specific trajectories of average cigarettes per day (ACPD) based on linear interpolation to estimate ACPD between exams 1 through 5 (ACPD 1‐5 ). We explored the associations of smoking status at exam 5, ACPD at exam 5, ACPD 1‐5 , and temporal change in smoking status, with ECV and nT1 using multivariable analysis. Results: Current smoking status was associated with increased markers of interstitial‐myocardial‐fibrosis in women but not in men, ECV% (ꞵ=2% P ≤0.001 versus 0.5%; P =0.2) and nT1 (ꞵ=28 ms; P ≤0.001 versus 3 ms; P =0.5) in women versus men, respectively. A higher ACPD 1‐5 was associated with increased ECV% (ꞵ=0.1%; P P =0.003) in women but not in men. Similarly, higher ACPD at exam 5 was associated with higher ECV% in women versus men. Sex interaction ascertained before stratification was statistically significant. Conclusions: In this population study, cigarette smoking was associated with a higher prevalence of interstitial‐myocardial‐fibrosis in women but not in men, indicating differences in the pathophysiology of cardiovascular disease by sex.
- Open Access
- 22 February 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (3) , 236
Age Is a Predictor of In-Hospital Outcomes for Left Ventricular Assist Device Implantation: A Nationwide Analysis
The 2018 heart allocation system has significantly influenced heart transplantation and left ventricular assist device (LVAD) utilization. Our study aims to investigate age-related outcomes following LVAD implantation in the post-allocation era. Using the National Inpatient Sample, we analyzed data from 7375 patients who underwent LVAD implantation between 2019 and 2020. The primary endpoint was in-hospital mortality following LVAD implantation, stratified by age categories. The age groups were 18–49, 50–59, 60–69, and over 70. These represented 26%, 26%, 31%, and 17% of patients, respectively. Patients aged 60–69 and those over 70 exhibited higher in-hospital mortality rates of 12% and 17%, respectively, compared to younger age groups (7% for 18–49 and 6% for 50–59). The age groups 60–69 and over 70 were independent predictors of mortality, with adjusted odds ratios of 1.99 (p = 0.02; 95% confidence interval [CI], 1.12–3.57) and 2.88 (p = 0.002; 95% CI, 1.45–5.71), respectively. Additionally, a higher Charlson Comorbidity Index was associated with increased in-hospital mortality risk (adjusted odds ratio 1.39; p = 0.02; 95% CI, 1.05–1.84). Additionally, patients above 70 experienced a statistically shorter length of stay. Nonhome discharge was found to be significantly high across all age categories. However, the difference in hospitalization cost was not statistically significant across the age groups. Our study highlights that patients aged 60 and above face an increased risk of in-hospital mortality following LVAD implantation in the post-allocation era. This study sheds light on age-related outcomes and emphasizes the importance of considering age in LVAD patient selection and management strategies.
- 22 February 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (3) , 236
Open AccessAge Is a Predictor of In-Hospital Outcomes for Left Ventricular Assist Device Implantation: A Nationwide Analysis
The 2018 heart allocation system has significantly influenced heart transplantation and left ventricular assist device (LVAD) utilization. Our study aims to investigate age-related outcomes following LVAD implantation in the post-allocation era. Using the National Inpatient Sample, we analyzed data from 7375 patients who underwent LVAD implantation between 2019 and 2020. The primary endpoint was in-hospital mortality following LVAD implantation, stratified by age categories. The age groups were 18–49, 50–59, 60–69, and over 70. These represented 26%, 26%, 31%, and 17% of patients, respectively. Patients aged 60–69 and those over 70 exhibited higher in-hospital mortality rates of 12% and 17%, respectively, compared to younger age groups (7% for 18–49 and 6% for 50–59). The age groups 60–69 and over 70 were independent predictors of mortality, with adjusted odds ratios of 1.99 (p = 0.02; 95% confidence interval [CI], 1.12–3.57) and 2.88 (p = 0.002; 95% CI, 1.45–5.71), respectively. Additionally, a higher Charlson Comorbidity Index was associated with increased in-hospital mortality risk (adjusted odds ratio 1.39; p = 0.02; 95% CI, 1.05–1.84). Additionally, patients above 70 experienced a statistically shorter length of stay. Nonhome discharge was found to be significantly high across all age categories. However, the difference in hospitalization cost was not statistically significant across the age groups. Our study highlights that patients aged 60 and above face an increased risk of in-hospital mortality following LVAD implantation in the post-allocation era. This study sheds light on age-related outcomes and emphasizes the importance of considering age in LVAD patient selection and management strategies.
- Open Access
- 22 November 2023
- Published by Elsevier in JACC: Advances
- Vol. 2 (10) , 100703
Reproductive Factors Linked With Myocardial Fibrosis
- 22 November 2023
- Published by Elsevier in JACC: Advances
- Vol. 2 (10) , 100703
Open AccessReproductive Factors Linked With Myocardial Fibrosis
- Open Access
- 10 May 2023
- Published by Elsevier in JACC: Advances
- Vol. 2 (3)
Endogenous Sex Hormone Levels and Myocardial Fibrosis in Men and Postmenopausal Women
- 10 May 2023
- Published by Elsevier in JACC: Advances
- Vol. 2 (3)
Open AccessEndogenous Sex Hormone Levels and Myocardial Fibrosis in Men and Postmenopausal Women
- 7 February 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (3) , e8146
Periodontal Disease Associated With Interstitial Myocardial Fibrosis: The Multiethnic Study of Atherosclerosis
Background: Periodontitis is a chronic inflammatory disease common among adults. It has been suggested that periodontal disease (PD) may be a contributing risk factor for cardiovascular disease; however, pathways underlying such a relationship require further investigation. Methods and Results: A total of 665 men (mean age 68±9 years) and 611 women (mean age 67±9 years) enrolled in the MESA (Multiethnic Study of Atherosclerosis) underwent PD assessment using a 2‐item questionnaire at baseline (2000–2002) and had cardiovascular magnetic resonance 10 years later. PD was defined when participants reported either a history of periodontitis or gum disease or lost teeth caused by periodontitis or gum disease. Multivariable linear regression models were constructed to assess the associations of baseline self‐reported PD with cardiovascular magnetic resonance–obtained measures of interstitial myocardial fibrosis (IMF), including extracellular volume and native T1 time. Men with a self‐reported history of PD had greater extracellular volume percent (ß=0.6%±0.2, P =0.01). This association was independent of age, left ventricular mass, traditional cardiovascular risk factors, and history of myocardial infarction. In a subsequent model, substituting myocardial infarction for coronary artery calcium score, the association of PD with IMF remained significant (ß=0.6%±0.3, P =0.03). In women, a self‐reported history of PD was not linked to higher IMF. Importantly, a self‐reported history of PD was not found to be associated with myocardial scar independent of sex (odds ratio, 1.01 [95% CI, 0.62–1.65]; P =0.9). Conclusions: In a community‐based setting, men but not women with a self‐reported PD history at baseline were found to be associated with increased measures of IMF. These findings support a plausible link between PD, a proinflammatory condition, and subclinical IMF.
- 7 February 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (3) , e8146
Periodontal Disease Associated With Interstitial Myocardial Fibrosis: The Multiethnic Study of Atherosclerosis
Background: Periodontitis is a chronic inflammatory disease common among adults. It has been suggested that periodontal disease (PD) may be a contributing risk factor for cardiovascular disease; however, pathways underlying such a relationship require further investigation. Methods and Results: A total of 665 men (mean age 68±9 years) and 611 women (mean age 67±9 years) enrolled in the MESA (Multiethnic Study of Atherosclerosis) underwent PD assessment using a 2‐item questionnaire at baseline (2000–2002) and had cardiovascular magnetic resonance 10 years later. PD was defined when participants reported either a history of periodontitis or gum disease or lost teeth caused by periodontitis or gum disease. Multivariable linear regression models were constructed to assess the associations of baseline self‐reported PD with cardiovascular magnetic resonance–obtained measures of interstitial myocardial fibrosis (IMF), including extracellular volume and native T1 time. Men with a self‐reported history of PD had greater extracellular volume percent (ß=0.6%±0.2, P =0.01). This association was independent of age, left ventricular mass, traditional cardiovascular risk factors, and history of myocardial infarction. In a subsequent model, substituting myocardial infarction for coronary artery calcium score, the association of PD with IMF remained significant (ß=0.6%±0.3, P =0.03). In women, a self‐reported history of PD was not linked to higher IMF. Importantly, a self‐reported history of PD was not found to be associated with myocardial scar independent of sex (odds ratio, 1.01 [95% CI, 0.62–1.65]; P =0.9). Conclusions: In a community‐based setting, men but not women with a self‐reported PD history at baseline were found to be associated with increased measures of IMF. These findings support a plausible link between PD, a proinflammatory condition, and subclinical IMF.
- 3 October 2022
- Published by SAGE Publications in Vascular Medicine
- Vol. 27 (6) , 557-564
Association of HIV infection with clinical features and outcomes of patients with aortic aneurysms
Data on the characteristics and outcomes of hospitalized patients with aortic aneurysms (AA) and HIV remain scarce. This is a cohort study of hospitalized adult patients with a diagnosis of AA from 2013 to 2019 using the US National Inpatient Readmission Database. Patients with a diagnosis of HIV were identified. Our outcomes included trends in hospitalizations and comparison of clinical characteristics, complications, and mortality in patients with AA and HIV compared to those without HIV. Among 1,905,837 hospitalized patients with AA, 4416 (0.23%) were living with HIV. There was an overall age-adjusted increase in the rate of HIV among patients hospitalized with AA over the years (14–29 per 10,000 person-years; age-adjusted p-trend < 0.001). Patients with AA and HIV were younger than those without HIV (median age: 60 vs 76 years, p < 0.001) and were less likely to have a history of smoking, hypertension, dyslipidemia, diabetes mellitus, and obesity. Thoracic aortic aneurysms were more prevalent in those with HIV (37.5% vs 26.7%, p < 0.001). On multivariable logistic regression, HIV was not associated with increased risk of aortic rupture (OR: 0.79; 95% CI: 0.61–1.01, p = 0.06), acute aortic dissection (OR: 0.73; 95% CI: 0.51–1.06, p = 0.3), readmissions (OR: 1.04; 95% CI: 0.95–1.13, p = 0.4), or aortic repair (OR: 0.89; 95% CI: 0.79–1.00, p = 0.05). Hospitalized patients with AA and HIV had a lower crude mortality rate compared to those without HIV (OR: 0.75 (0.63–0.91), p = 0.003). Hospitalized patients with AA and HIV likely constitute a distinct group of patients with AA; they are younger, have fewer traditional cardiovascular risk factors, and a higher rate of thoracic aorta involvement. Differences in clinical features may account for the lower mortality rate observed in patients with AA and HIV compared to those without HIV.
- 3 October 2022
- Published by SAGE Publications in Vascular Medicine
- Vol. 27 (6) , 557-564
Association of HIV infection with clinical features and outcomes of patients with aortic aneurysms
Data on the characteristics and outcomes of hospitalized patients with aortic aneurysms (AA) and HIV remain scarce. This is a cohort study of hospitalized adult patients with a diagnosis of AA from 2013 to 2019 using the US National Inpatient Readmission Database. Patients with a diagnosis of HIV were identified. Our outcomes included trends in hospitalizations and comparison of clinical characteristics, complications, and mortality in patients with AA and HIV compared to those without HIV. Among 1,905,837 hospitalized patients with AA, 4416 (0.23%) were living with HIV. There was an overall age-adjusted increase in the rate of HIV among patients hospitalized with AA over the years (14–29 per 10,000 person-years; age-adjusted p-trend < 0.001). Patients with AA and HIV were younger than those without HIV (median age: 60 vs 76 years, p < 0.001) and were less likely to have a history of smoking, hypertension, dyslipidemia, diabetes mellitus, and obesity. Thoracic aortic aneurysms were more prevalent in those with HIV (37.5% vs 26.7%, p < 0.001). On multivariable logistic regression, HIV was not associated with increased risk of aortic rupture (OR: 0.79; 95% CI: 0.61–1.01, p = 0.06), acute aortic dissection (OR: 0.73; 95% CI: 0.51–1.06, p = 0.3), readmissions (OR: 1.04; 95% CI: 0.95–1.13, p = 0.4), or aortic repair (OR: 0.89; 95% CI: 0.79–1.00, p = 0.05). Hospitalized patients with AA and HIV had a lower crude mortality rate compared to those without HIV (OR: 0.75 (0.63–0.91), p = 0.003). Hospitalized patients with AA and HIV likely constitute a distinct group of patients with AA; they are younger, have fewer traditional cardiovascular risk factors, and a higher rate of thoracic aorta involvement. Differences in clinical features may account for the lower mortality rate observed in patients with AA and HIV compared to those without HIV.
- 4 May 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 174, 76-83
Incidence and Outcomes of Gastrointestinal Bleeding in Patients With Percutaneous Mechanical Circulatory Support Devices
- 4 May 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 174, 76-83
Incidence and Outcomes of Gastrointestinal Bleeding in Patients With Percutaneous Mechanical Circulatory Support Devices